Its not the most aggressive pressure tactic Ive seen, but for a monthly medical subscription, its unnecessary
For the 17mg/mL concentration, a 0.5 mL syringe works perfectly for doses up to 7.5mg (44 units)
Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 receptor agonist (GLP-1 RA), has shown superior efficacy in glycemic control, weight loss and cardiometabolic outcomes compared to GLP-1 agonists alone
Our capabilities include full-scale formulation development, API sourcing, and finished dosage form manufacturing, with flexibility to accommodate custom specifications
Both rates remain acceptable and significantly lower than many older weight loss medications
Trends Food Sci Technol Elsevier